Consortium

10 partners | 7 countries

PRINCIPAL INVESTIGATORS

University of Athens

Professor Nikolaos Papadopoulos

Professor Nikolaos Papadopoulos. MD, PHD is Professor of Allergy and Paediatric Allergy and Head of the Allergy Unit, 2nd Paediatric Clinic of the NKUA (www.allergy1.gr). He completed his undergraduate and post-graduate studies at the NKUA and continued with his specialist training in Paediatric and Allergology in the NKUA and the UK. He also holds a Chair at the University of Manchester, UK and is Past President of the European Academy of Allergy and Clinical Immunology (EAACI) – the world’s largest scientific organization in the field of Allergology. Focusing on respiratory viral infections and their association to reactive airway disease, he has published more than 250 papers with over 17000 citations (H-index: 55, i10-index: 183), received several international awards and is invited to speak at international scientific meetings some 30 times a year. He has extensive experience in EU projects, participating in all Framework Programs since FP4 and recently completed coordinating the FP7 PreDicta. Ηe has supervised 17 PhD students and currently supervises 4 thesis projects.

Professor David Robertson

University of Manchester

Professor David Robertson is Professor of Computational and Evolutionary Biology exploring viral and molecular evolution, genomics and disease. He has over 150 publications looking into viral diversity and  evolution, metagenomics and the virome, viral analysis workflows, viral-host interaction networks, human disease & mutation and digital signal processing for next generation sequencing data. His team has created various computational tools for metagenomic and sequence analysis including Alignment_by_numbers: sequence analysis using numerical representations and compressed transformations BioNerDS: text mining bioinformatics database and software names, CTree: cluster analysis for phylogenetic trees, Coverage: characterization of HIV-1 k-mer space, Interview: 2D visualisation of network data, JNets: network visualisation and analysis tool, MrGBP: multi- resolution genomic binary patterns method, Recombination resources: tools for analysis of recombinant sequences, Segminator: analysis of high-throughput viral sequence data, Trogen: genotypic HIV-1 tropism prediction, and TVi: network visualisation in a phylogenetic context.

Swiss Institute of Allergy and Asthma Research

Dr Mübeccel Akdis

Dr Mübeccel Akdis SIAF. Dr Akdis is working in the Swiss Institute of Allergy and Asthma Research (SIAF) since 1995 and received her PhD in Immunology. Dr Akdis worked as a postdoctoral scientist and became a group leader at SIAF, where she has established her own research group in 2003. Dr Akdis made her habilitation (Venia Legendi) in Zurich University Medical Faculty on Experimental Immunology in 2005 and became a professor in 2015. Her major research contributions are on mechanisms of allergen tolérance, high dose allergen exposure models in humans, mechanisms of allergen-specific immunotherapy, functions of T regulatory cells, NK regulatory cells and IL-10 producing human B regulatory cells. She has received research grants and collaborative grants   from the Swiss National Foundation and European Union. She received numerous awards, including Ferdinand Wortman Prize, Professor Hans Storck Award, Sedat Simavi Medicine Award. She is in the editorial board of the Journals Allergy, European Journal of Immunology, International Archieves of Allergy Immunology and served her term in the éditorial board of Journal of Allergy Clinical Immunology between 2011 and 2015. She worked in the Immunology Section Board of the European Academy of Allergy and Clinical Immunology. Se is currently board member of the World Allergy Organization (WAO), and has taken active roles in the organization of several EAACI Davos, Immunology Winter Schools and all of the World Immune Regulation Meetings (WIRM) since their  initiation in 2007. She has more than 200 publications, h:index is 58, articles cited more than 100 times is 36, total impact factor of her publications is 1204.

Biomedical Research Foundation
Academy of Athens

Dr  Evangelos  Andreakos

Dr  Evangelos  Andreakos,  PhD is  Principal  Investigator  and  Associate  Professor  at  the  Centre  for Translational and Clinical Research at BRFAA. Dr Andreakos trained in Immunology at Imperial College London and the Kennedy Institute for over 10 years. He has published 50 articles in leading international journals such as PNAS, Science Transl Med, Circulation, Blood, EMBO Mol Med and Αm J Respir Crit Care Med,, half of which as main author (first or last), and has contributed chapters to influential books in the field including the Global Atlas of Allergies commissioned by EAACI. He is a regular referee for high impact journals (J Clin Invest, Science Transl Med, Blood, EMBO Mol Med, J Allergy Clin Immunol etc) and an Expert Evaluator/Panel member for several funding bodies including the European Commission, Agence Nationale de la Recherche (ANR, France), Asthma Research UK, Netherlands Lung Foundation and the Catalonian Agency of Health and Technology. He is also an inventor in three patents on mechanisms and experimental therapeutics for respiratory diseases. Dr Andreakos research focuses on the role of innate immunity in respiratory infections, exacerbations of respiratory disease (asthma and COPD) and modulation of respiratory inflammation. He has long experience in mouse models of respiratory infections (HRV, influenza etc), allergic airway inflammation, asthma and COPD, and has recently developed unique mice for the tracking and ablation of macrophage/DC subpopulations. He also has unique know-how on basic immunology, macrophage/DC biology, transcriptomics and mouse lung physiology.

University of Lodz

Professor Marek L. Kowalski

Professor Marek L. Kowalski is the Chair at Department of Clinical Immunology and Microbiology, and Director of the Healthy Ageing Research Center (HARC), Faculty of Medicine at the Medical University in Lodz. Medical and doctorate degrees he received from the Medical University in Lodz, and for three years was a Visiting Fellow at the National Institutes of Health, Bethesda, USA. Professor Kowalski is board certified in internal medicine, allergology and clinical immunology and currently is heading Allergy, Asthma and Immunology Clinic at the University Hospital in Lodz. He was the Treasurer of the European Academy of Allergy and Clinical  Immunology (EAACI), the president of the 2009 EAACI Congress in Warsaw, President of the Polish Society of Allergology and Board of Directors member at the World Allergy Organization. Prof. Kowalski is the editor–in– chief of “Alergia Astma Immunologia” and serves on editorial boards for several international journals. In 2015, he was awarded the EAACI Daniel Bovet Award for Treatment & Prevention in Allergic Diseases. At present he is the coordinator of the FP7 RegPot Project (2013-2016) “Healthy Ageing Research Center” and partner in three EC funded IP projects. His major research interests include pathogenesis and management of bronchial asthma,  COPD and chronic rhinosinusitis, immunology of respiratory infections, immunology of ageing and  hypersensitivity to NSAIDs. He has authored or co-authored more than 300 publications.

Umea Universitet

Xavier Thibert-Plante

Xavier Thibert-Plante  is a computational biologist who specialize on numerical models of ecology and evolution. His education is in physics, computer science, and biology. He did a postdoc in mathematical biology at the National institute for mathematical and biological synthesis. Since then, he works on large scale numerical models of complex ecological phenomena. Xavier is now a principal investigator at Icelab, an interdisciplinary environment bridging the departments of ecology  and environmental science with the department of physics,  and the department of mathematics and statistics at Umeå University.

Giorgi Eliava Institute

of Bacteriophagy, Microbiology and Virology

Dr. Nina Cahnishvili

Dr. Nina Cahnishvili  has been working at the Eliava Institute of Bacteriophage, Microbiology and Virology since 1976. During her career she has grown from the position of Junior researcher to Head of Research and Development. During the period 1997-2016 Dr. Chanishvili has been  managing  participating  in  about  40 projects, funded by local and international funding organizations, such as RNSF, CRDF, GRDF, INTAS, ISTC, NATO Science for Peace, SNSF, EU 7FP,  etc. In EU 7FP-2011-IAPP-286464 (NanoBacteriophageSERS) she played a role of a work package manager. She has participated in many Consortia meetings (kick-off, interim and final). Thus, Dr. Chanishvili is familiar with the FP rules, especially as management procedures of the EC projects throughout the project life cycle (day-to-day management, reporting, audit, etc.). She has > 10 years of teaching experience at different Georgian universities. Four PhD and over 15 MSc thesis have been implemented under Dr. Chanishvili’s supervision. She has been a reviewer of several impact factor journals and worked as an evaluator of EU and  GNSF projects. She is an author of over 120 abstracts, articles and monographs.

Eliava BIO Preparations LTD

Dr. Marina Goderdzishvili

Dr. Marina Goderdzishvili

Academic Degrees : PhD in Microbiology - Moscow Gamalea Institute of Epidemiology and Microbiology ; High Attestation Commission of the USSR, Moscow

Work Experience : 1983- at present - G.Eliava Institute of Bacteriophages, Microbiology and Virology,  Head of  the Laboratory of  General Microbiology

Since 2008 -  at present -  Eliava BioPreparations, Ltd. Leading scientist. Head of the group. 12 international  grant projects; 15 publications ;  44 abstracts in scientific forums; 6 patents.

© 2017 Cure. Eubiosis Reinstatement Therapy

  • Twitter Social Icon

 

 

 

 

 

This project has received funding from the European Union’s Horizon 2020 research

and innovation programme under grant agreement No 767015.

The content of this website reflects only the views of its authors.

The European Commission is not responsible for any use that may be made of the information it contains